Opioid reduction and enhanced recovery in orthopaedic surgery (OREOS): a protocol for a feasibility randomised controlled trial in patients undergoing total knee arthroplasty.
Feasibility
Knee arthroplasty
Multicomponent intervention
Opioid reduction
Persisting pain
Journal
Pilot and feasibility studies
ISSN: 2055-5784
Titre abrégé: Pilot Feasibility Stud
Pays: England
ID NLM: 101676536
Informations de publication
Date de publication:
15 Feb 2024
15 Feb 2024
Historique:
received:
26
01
2023
accepted:
25
01
2024
medline:
16
2
2024
pubmed:
16
2
2024
entrez:
15
2
2024
Statut:
epublish
Résumé
Knee arthritis is a leading cause of limited function and long-term disability in older adults. Despite a technically successful total knee arthroplasty (TKA), around 20% of patients continue to have persisting pain with reduced function, and low quality of life. Many of them continue using opioids for pain control, which puts them at risk for potential long-term adverse effects such as dependence, overdose and risk of falls. Although persisting pain and opioid use after TKA have been recognised to be important issues, individual strategies to decrease their burden have limitations and multi-component interventions, despite their potential, have not been well studied. In this study, we propose a multi-component pathway including personalized pain management, facilitated by a pain management coordinator. The objectives of this pilot trial are to evaluate feasibility (recruitment, retention, and adherence), along with opioid-free pain control at 8 weeks after TKA. This is a protocol for a multicentre pilot randomised controlled trial using a 2-arm parallel group design. Adult participants undergoing unilateral total knee arthroplasty will be considered for inclusion and randomised to control and intervention groups. Participants in the intervention group will receive support from a pain management coordinator who will facilitate a multicomponent pain management pathway including (1) preoperative education on pain and opioid use, (2) preoperative risk identification and mitigation, (3) personalized post-discharge analgesic prescriptions and (4) continued support for pain control and recovery up to 8 weeks post-op. Participants in the control group will undergo usual care. The primary outcomes of this pilot trial are to assess the feasibility of participant recruitment, retention, and adherence to the interventions, and key secondary outcomes are persisting pain and opioid use. The results of this trial will determine the feasibility of conducting a definitive trial for the implementation of a multicomponent pain pathway to improve pain control and reduce harms using a coordinated approach, while keeping an emphasis on patient centred care and shared decision making. Prospectively registered in Clinicaltrials.gov (NCT04968132).
Sections du résumé
BACKGROUND
BACKGROUND
Knee arthritis is a leading cause of limited function and long-term disability in older adults. Despite a technically successful total knee arthroplasty (TKA), around 20% of patients continue to have persisting pain with reduced function, and low quality of life. Many of them continue using opioids for pain control, which puts them at risk for potential long-term adverse effects such as dependence, overdose and risk of falls. Although persisting pain and opioid use after TKA have been recognised to be important issues, individual strategies to decrease their burden have limitations and multi-component interventions, despite their potential, have not been well studied. In this study, we propose a multi-component pathway including personalized pain management, facilitated by a pain management coordinator. The objectives of this pilot trial are to evaluate feasibility (recruitment, retention, and adherence), along with opioid-free pain control at 8 weeks after TKA.
METHODS
METHODS
This is a protocol for a multicentre pilot randomised controlled trial using a 2-arm parallel group design. Adult participants undergoing unilateral total knee arthroplasty will be considered for inclusion and randomised to control and intervention groups. Participants in the intervention group will receive support from a pain management coordinator who will facilitate a multicomponent pain management pathway including (1) preoperative education on pain and opioid use, (2) preoperative risk identification and mitigation, (3) personalized post-discharge analgesic prescriptions and (4) continued support for pain control and recovery up to 8 weeks post-op. Participants in the control group will undergo usual care. The primary outcomes of this pilot trial are to assess the feasibility of participant recruitment, retention, and adherence to the interventions, and key secondary outcomes are persisting pain and opioid use.
DISCUSSION
CONCLUSIONS
The results of this trial will determine the feasibility of conducting a definitive trial for the implementation of a multicomponent pain pathway to improve pain control and reduce harms using a coordinated approach, while keeping an emphasis on patient centred care and shared decision making.
TRIAL REGISTRATION
BACKGROUND
Prospectively registered in Clinicaltrials.gov (NCT04968132).
Identifiants
pubmed: 38360686
doi: 10.1186/s40814-024-01457-9
pii: 10.1186/s40814-024-01457-9
doi:
Banques de données
ClinicalTrials.gov
['NCT04968132']
Types de publication
Journal Article
Langues
eng
Pagination
30Informations de copyright
© 2024. The Author(s).
Références
Government of Canada SC. Arthritis, by age group. 2017. Available from: https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1310009606 . Cited 2022 Dec 14.
The Truth About Arthritis - Prevalence & Impact. Available from: https://arthritis.ca/about-arthritis/what-is-arthritis/the-truth-about-arthritis . Cited 2022 Dec 14.
Inpatient Hospitalizations, Surgeries, Newborns and Childbirth Indicators, 2016–2017 — CIHI Snapshot.
CJRR annual report: Hip and knee replacements in Canada | CIHI. Available from: https://www.cihi.ca/en/cjrr-annual-report-hip-and-knee-replacements-in-canada . Cited 2022 Dec 14.
Beswick AD, Wylde V, Gooberman-Hill R, Blom A, Dieppe P. What proportion of patients report long-term pain after total hip or knee replacement for osteoarthritis? A systematic review of prospective studies in unselected patients. BMJ Open. 2012;2(1): e000435.
pubmed: 22357571
pmcid: 3289991
doi: 10.1136/bmjopen-2011-000435
Bourne RB, Chesworth BM, Davis AM, Mahomed NN, Charron KDJ. Patient satisfaction after total knee arthroplasty: who is satisfied and who is not? Clin Orthop Relat Res. 2010;468(1):57–63.
pubmed: 19844772
doi: 10.1007/s11999-009-1119-9
Rice DA, Kluger MT, McNair PJ, Lewis GN, Somogyi AA, Borotkanics R, et al. Persistent postoperative pain after total knee arthroplasty: a prospective cohort study of potential risk factors. Br J Anaesth. 2018;121(4):804–12.
pubmed: 30236242
doi: 10.1016/j.bja.2018.05.070
Correll D. Chronic postoperative pain: recent findings in understanding and management. F1000Research; 2017 . Available from: https://f1000research.com/articles/6-1054 . Cited 2022 Dec 14.
Glare P, Aubrey KR, Myles PS. Transition from acute to chronic pain after surgery. The Lancet. 2019;393(10180):1537–46.
doi: 10.1016/S0140-6736(19)30352-6
Smith SR, Bido J, Collins JE, Yang H, Katz JN, Losina E. Impact of preoperative opioid use on total knee arthroplasty outcomes. JBJS. 2017;99(10):803–8.
doi: 10.2106/JBJS.16.01200
Grosu I, Lavand’homme P, Thienpont E. Pain after knee arthroplasty: an unresolved issue. Knee Surg Sports Traumatol Arthrosc. 2014;22(8):1744–58.
pubmed: 24201900
doi: 10.1007/s00167-013-2750-2
Buvanendran A, Valle CJD, Kroin JS, Shah M, Moric M, Tuman KJ, et al. Acute postoperative pain is an independent predictor of chronic postsurgical pain following total knee arthroplasty at 6 months: a prospective cohort study. Reg Anesth Pain Med. 2019;44(3). Available from: https://rapm.bmj.com/content/44/3/e100036 . Cited 2022 Dec 14.
Andersen LØ, Gaarn-Larsen L, Kristensen BB, Husted H, Otte KS, Kehlet H. Subacute pain and function after fast-track hip and knee arthroplasty. Anaesthesia. 2009;64(5):508–13.
pubmed: 19413820
doi: 10.1111/j.1365-2044.2008.05831.x
Shechter R, Speed TJ, Blume E, Singh S, Williams K, Koch CG, et al. Addressing the opioid crisis one surgical patient at a time: outcomes of a novel perioperative pain program. Am J Med Qual. 2020;35(1):5–15.
pubmed: 31129979
doi: 10.1177/1062860619851170
Alexander JC, Patel B, Joshi GP. Perioperative use of opioids: current controversies and concerns. Best Pract Res Clin Anaesthesiol. 2019;33(3):341–51.
pubmed: 31785719
doi: 10.1016/j.bpa.2019.07.009
Egan TD. Are opioids indispensable for general anaesthesia? Br J Anaesth. 2019;122(6):e127–35.
pubmed: 31104756
doi: 10.1016/j.bja.2019.02.018
Shanthanna H, Ladha KS, Kehlet H, Joshi GP. Perioperative opioid administration: a critical review of opioid-free versus opioid-sparing approaches. Anesthesiology. 2021;134(4):645–59.
pubmed: 32991672
doi: 10.1097/ALN.0000000000003572
Jivraj NK, Raghavji F, Bethell J, Wijeysundera DN, Ladha KS, Bateman BT, et al. Persistent postoperative opioid use: a systematic literature search of definitions and population-based cohort study. Anesthesiology. 2020;132(6):1528–39.
pubmed: 32243330
doi: 10.1097/ALN.0000000000003265
Sun EC, Darnall BD, Baker LC, Mackey S. Incidence of and risk factors for chronic opioid use among opioid-naive patients in the postoperative period. JAMA Intern Med. 2016;176(9):1286–93.
pubmed: 27400458
pmcid: 6684468
doi: 10.1001/jamainternmed.2016.3298
Rudd RA. Increases in drug and opioid-involved overdose deaths—United States, 2010–2015. MMWR Morb Mortal Wkly Rep. 2016 ;65. Available from: https://www.cdc.gov/mmwr/volumes/65/wr/mm655051e1.htm . Cited 2022 Dec 14.
Wheeler M, Oderda GM, Ashburn MA, Lipman AG. Adverse events associated with postoperative opioid analgesia: a systematic review. J Pain. 2002;3(3):159–80.
pubmed: 14622770
doi: 10.1054/jpai.2002.123652
Power JD, Perruccio AV, Gandhi R, Veillette C, Davey JR, Lewis SJ, Syed K, Mahomed NN, Rampersaud YR. Factors associated with opioid use in presurgical knee, hip, and spine osteoarthritis patients. Arthritis Care Res (Hoboken). 2019;71(9):1178–85.
pubmed: 30629338
doi: 10.1002/acr.23831
Cook DJ, Kaskovich SW, Pirkle SC, Mica MAC, Shi LL, Lee MJ. Benchmarks of duration and magnitude of opioid consumption after total hip and knee arthroplasty: a database analysis of 69,368 patients. J Arthroplasty. 2019;34(4):638-44.e1.
pubmed: 30642706
doi: 10.1016/j.arth.2018.12.023
Hah JM, Bateman BT, Ratliff J, Curtin C, Sun E. Chronic opioid use after surgery: implications for perioperative management in the face of the opioid epidemic. Anesth Analg. 2017;125(5):1733–40.
pubmed: 29049117
pmcid: 6119469
doi: 10.1213/ANE.0000000000002458
Zarling BJ, Yokhana SS, Herzog DT, Markel DC. Preoperative and postoperative opiate use by the arthroplasty patient. J Arthroplasty. 2016;31(10):2081–4.
pubmed: 27161903
doi: 10.1016/j.arth.2016.03.061
Fujii MH, Hodges AC, Russell RL, Roensch K, Beynnon B, Ahern TP, et al. Post-discharge opioid prescribing and use after common surgical procedure. J Am Coll Surg. 2018;226(6):1004–12.
pubmed: 29499361
pmcid: 5971152
doi: 10.1016/j.jamcollsurg.2018.01.058
Thiels CA, Ubl DS, Yost KJ, Dowdy SC, Mabry TM, Gazelka HM, et al. Results of a prospective, multicenter initiative aimed at developing opioid-prescribing guidelines after surgery. Ann Surg. 2018;268(3):457–68.
pubmed: 30004924
doi: 10.1097/SLA.0000000000002919
Edwards DA, Hedrick TL, Jayaram J, Argoff C, Gulur P, Holubar SD, et al. American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on Perioperative Management of Patients on Preoperative Opioid Therapy. Anesth Analg. 2019;129(2):553–66.
pubmed: 30768461
doi: 10.1213/ANE.0000000000004018
Reid DBC, Shah KN, Shapiro BH, Ruddell JH, Akelman E, Daniels AH. Mandatory prescription limits and opioid utilization following orthopaedic surgery. JBJS. 2019;101(10): e43.
doi: 10.2106/JBJS.18.00943
Sabesan VJ, Chatha K, Koen S, Dawoud M, Gilot G. Innovative patient education and pain management protocols to achieve opioid-free shoulder arthroplasty. JSES Int. 2020;4(2):362–5.
pubmed: 32490427
pmcid: 7256883
doi: 10.1016/j.jseint.2020.01.005
Fiore JF, Olleik G, El-Kefraoui C, Verdolin B, Kouyoumdjian A, Alldrit A, et al. Preventing opioid prescription after major surgery: a scoping review of opioid-free analgesia. Br J Anaesth. 2019;123(5):627–36.
pubmed: 31563269
doi: 10.1016/j.bja.2019.08.014
Gormley J, Gouveia K, Sakha S, Stewart V, Emmanuel U, Shehata M, et al. Reduction of opioid use after orthopedic surgery: a scoping review. Can J Surg. 2022;65(5):E695-715.
pubmed: 36265899
pmcid: 9592092
doi: 10.1503/cjs.023620
Tedesco D, Gori D, Desai KR, Asch S, Carroll IR, Curtin C, et al. Drug-free interventions to reduce pain or opioid consumption after total knee arthroplasty: a systematic review and meta-analysis. JAMA Surg. 2017;152(10): e172872.
pubmed: 28813550
pmcid: 5831469
doi: 10.1001/jamasurg.2017.2872
Talboys R, Mak M, Modi N, Fanous N, Cutts S. Enhanced recovery programme reduces opiate consumption in hip hemiarthroplasty. Eur J Orthop Surg Traumatol. 2016;26(2):177–81.
pubmed: 26559539
doi: 10.1007/s00590-015-1722-2
Pagé MG, Katz J, Romero Escobar EM, Lutzky-Cohen N, Curtis K, Fuss S, et al. Distinguishing problematic from nonproblematic postsurgical pain: a pain trajectory analysis after total knee arthroplasty. PAIN. 2015;156(3):460–8.
pubmed: 25599235
doi: 10.1097/01.j.pain.0000460327.10515.2d
Vetter TR, Kain ZN. Role of the Perioperative Surgical Home in Optimizing the Perioperative Use of Opioids. Anesth Analg. 2017;125(5):1653–7.
pubmed: 28742770
doi: 10.1213/ANE.0000000000002280
Cline KM, Clement V, Rock-Klotz J, Kash BA, Steel C, Miller TR. Improving the cost, quality, and safety of perioperative care: a systematic review of the literature on implementation of the perioperative surgical home. J Clin Anesth. 2020;1(63): 109760.
doi: 10.1016/j.jclinane.2020.109760
Admiraal M, Hermanns H, Hermanides J, Wensing CGCL, Meinsma SL, Wartenberg HCH, et al. Study protocol for the TRUSt trial: a pragmatic randomised controlled trial comparing the standard of care with a transitional pain service for patients at risk of chronic postsurgical pain undergoing surgery. BMJ Open. 2021;11(8): e049676.
pubmed: 34389577
pmcid: 8365802
doi: 10.1136/bmjopen-2021-049676
Carroll IR, Hah JM, Barelka PL, Wang CKM, Wang BM, Gillespie MJ, et al. Pain duration and resolution following surgery: an inception cohort study. Pain Med. 2015;16(12):2386–96.
pubmed: 26179223
doi: 10.1111/pme.12842
Cai L, Gao H, Xu H, Wang Y, Lyu P, Liu Y. Does a program based on cognitive behavioral therapy affect kinesiophobia in patients following total knee arthroplasty? A randomized, controlled trial with a 6-month follow-up. J Arthroplasty. 2018;33(3):704–10.
pubmed: 29239772
doi: 10.1016/j.arth.2017.10.035
Joshi GP, Kehlet H. Postoperative pain management in the era of ERAS: an overview. Best Pract Res Clin Anaesthesiol. 2019;33(3):259–67. https://doi.org/10.1016/j.bpa.2019.07.016 .
doi: 10.1016/j.bpa.2019.07.016
pubmed: 31785712
Hah JM, Trafton JA, Narasimhan B, Krishnamurthy P, Hilmoe H, Sharifzadeh Y, Huddleston JI, Amanatullah D, Maloney WJ, Goodman S, Carroll I. Efficacy of motivational-interviewing and guided opioid tapering support for patients undergoing orthopedic surgery (MI-Opioid Taper): A prospective, assessor-blind, randomized controlled pilot trial. EClinicalMedicine. 2020;1(28): 100596.
doi: 10.1016/j.eclinm.2020.100596
Gilron I, Carr DB, Desjardins PJ, Kehlet H. Current methods and challenges for acute pain clinical trials. Pain Rep. 2018;4(3): e647.
pubmed: 31583333
pmcid: 6749920
doi: 10.1097/PR9.0000000000000647
Hah J, Mackey SC, Schmidt P, McCue R, Humphreys K, Trafton J, et al. Effect of perioperative gabapentin on postoperative pain resolution and opioid cessation in a mixed surgical cohort: a randomized clinical trial. JAMA Surg. 2018;153(4):303–12.
pubmed: 29238824
doi: 10.1001/jamasurg.2017.4915
Wylde V, MacKichan F, Bruce J, Gooberman-Hill R. Assessment of chronic post-surgical pain after knee replacement: development of a core outcome set. Eur J Pain. 2015;19(5):611–20.
pubmed: 25154614
doi: 10.1002/ejp.582
Treede RD, Rief W, Barke A, Aziz Q, Bennett MI, Benoliel R, Cohen M, Evers S, Finnerup NB, First MB, Giamberardino MA, Kaasa S, Korwisi B, Kosek E, Lavand’homme P, Nicholas M, Perrot S, Scholz J, Schug S, Smith BH, Svensson P, Vlaeyen JWS, Wang SJ. Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11). Pain. 2019;160(1):19–27.
pubmed: 30586067
doi: 10.1097/j.pain.0000000000001384
Clement ND, MacDonald D, Simpson AH. The minimal clinically important difference in the Oxford knee score and Short Form 12 score after total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc. 2014;22(8):1933–9. https://doi.org/10.1007/s00167-013-2776-5 . (Epub 2013 Nov 20).
doi: 10.1007/s00167-013-2776-5
pubmed: 24253376
Bilbao A, García-Pérez L, Arenaza JC, García I, Ariza-Cardiel G, Trujillo-Martín E, Forjaz MJ, Martín-Fernández J. Psychometric properties of the EQ-5D-5L in patients with hip or knee osteoarthritis: reliability, validity and responsiveness. Qual Life Res. 2018;27(11):2897–908.
pubmed: 29978346
doi: 10.1007/s11136-018-1929-x
Schug SA, Lavand’homme P, Barke A, Korwisi B, Rief W, Treede RD, et al. The IASP classification of chronic pain for ICD-11: chronic postsurgical or posttraumatic pain. PAIN. 2019;160(1):45–52.
pubmed: 30586070
doi: 10.1097/j.pain.0000000000001413
Busse JW, Bhandari M, Einhorn TA, Schemitsch E, Heckman JD, 3rd Tornetta P, Leung KS, Heels-Ansdell D, Makosso-Kallyth S, Della Rocca GJ, Jones CB, Guyatt GH, TRUST Investigators writing group. Re-evaluation of low intensity pulsed ultrasound in treatment of tibial fractures (TRUST): randomized clinical trial. BMJ. 2016;355:i5351.
pubmed: 27797787
pmcid: 5080447
The Oxford Knee Score. Oxford University Innovation. Available from: https://innovation.ox.ac.uk/outcome-measures/oxford-knee-score-oks/ . Cited 2022 Dec 14.
Ray GS, Ekelund P, Nemes S, Rolfson O, Mohaddes M. Changes in health-related quality of life are associated with patient satisfaction following total hip replacement: an analysis of 69,083 patients in the Swedish Hip Arthroplasty Register. Acta Orthop. 2019;91(1):48–52.
pubmed: 31680594
pmcid: 7008235
doi: 10.1080/17453674.2019.1685284
Tarride JE, Hopkins RB, Blackhouse G, Burke N, Bhandari M, Johal H, et al. Low-intensity pulsed ultrasound for treatment of tibial fractures. Bone Jt J. 2017;99-B(11):1526–32.
doi: 10.1302/0301-620X.99B11.BJJ-2017-0737
Madden K, Scott T, McKay P, Petrisor BA, Jeray KJ, Tanner SL, et al. Predicting and preventing loss to follow-up of adult trauma patients in randomized controlled trials: an example from the FLOW Trial. JBJS. 2017;99(13):1086–92.
doi: 10.2106/JBJS.16.00900
PREP-IT Investigators. Aqueous skin antisepsis before surgical fixation of open fractures (Aqueous-PREP): a multiple-period, cluster-randomised, crossover trial. The Lancet. 2022 Oct 15;400(10360):1334–44.
HEALTH Investigators; Bhandari M, Einhorn TA, Guyatt G, Schemitsch EH, Zura RD, Sprague S, Frihagen F, Guerra-Farfán E, Kleinlugtenbelt YV, Poolman RW, Rangan A, Bzovsky S, Heels-Ansdell D, Thabane L, Walter SD, Devereaux PJ. Total Hip Arthroplasty or Hemiarthroplasty for Hip Fracture. N Engl J Med. 2019;381(23):2199–208.
pubmed: 31557429
doi: 10.1056/NEJMoa1906190
FLOW Investigators; Bhandari M, Jeray KJ, Petrisor BA, Devereaux PJ, Heels-Ansdell D, Schemitsch EH, Anglen J, Della Rocca GJ, Jones C, Kreder H, Liew S, McKay P, Papp S, Sancheti P, Sprague S, Stone TB, Sun X, Tanner SL, Tornetta P 3rd, Tufescu T, Walter S, Guyatt GH. A trial of wound irrigation in the initial management of open fracture wounds. N Engl J Med. 2015 Dec 31;373(27):2629–41.
Nauth A, Creek AT, Zellar A, Lawendy AR, Dowrick A, Gupta A, et al. Fracture fixation in the operative management of hip fractures (FAITH): an international, multicentre, randomised controlled trial. The Lancet. 2017;389(10078):1519–27.
doi: 10.1016/S0140-6736(17)30066-1
Thabane L, Ma J, Chu R, Cheng J, Ismaila A, Rios LP, et al. A tutorial on pilot studies: the what, why and how. BMC Med Res Methodol. 2010;10(1):1.
pubmed: 20053272
pmcid: 2824145
doi: 10.1186/1471-2288-10-1
Xie F, Pullenayegum E, Gaebel K, Bansback N, Bryan S, Ohinmaa A, et al. A time trade-off-derived value set of the EQ-5D-5L for Canada. Med Care. 2016;54(1):98–105.
pubmed: 26492214
doi: 10.1097/MLR.0000000000000447